ABT-510 acetate is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 acetate also reduces angiogenesis and inflammatory responses in a murine model of inflammatory bowel disease. ABT-510 acetate can be used in studies of cancer (particularly epithelial ovarian cancer) and inflammatory bowel disease (IBD)[1][2].
Molecular Weight:
1054.28
Purity:
99.61
CAS Number:
[442526-87-6]
Formula:
C48H87N13O13
Target:
Apoptosis
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
